Janney Montgomery Scott Downgrades Cerulean Pharma (CERU) to Neutral
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Price: $0.66 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Janney Montgomery Scott downgraded Cerulean Pharma (NASDAQ: CERU) from Buy to Neutral with a price target of $1.00 (from $6.00).
For an analyst ratings summary and ratings history on Cerulean Pharma click here. For more ratings news on Cerulean Pharma click here.
Shares of Cerulean Pharma closed at $2.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Downgrades Swiss Prime Site AG (SPSN:SW) (SWPRF) to Equalweight
- Tritax Big Box REIT Plc. (BBOX:LN) PT Lowered to GBP1.70 at Barclays
- Beijing Kingsoft Office Software Inc (688111:CH) PT Lowered to RMB303 at Jefferies
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
